These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 9378550)

  • 21. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
    Diel P; Olff S; Schmidt S; Michna H
    J Steroid Biochem Mol Biol; 2002 Jan; 80(1):61-70. PubMed ID: 11867264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.
    Sommer A; Hoffmann J; Lichtner RB; Schneider MR; Parczyk K
    J Steroid Biochem Mol Biol; 2003 May; 85(1):33-47. PubMed ID: 12798355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
    Bouker KB; Skaar TC; Fernandez DR; O'Brien KA; Riggins RB; Cao D; Clarke R
    Cancer Res; 2004 Jun; 64(11):4030-9. PubMed ID: 15173018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J; Kitlen JW; Briand P; Labrie F; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):469-78. PubMed ID: 12732292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens.
    Hua W; Christianson T; Rougeot C; Rochefort H; Clinton GM
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):279-89. PubMed ID: 8541224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.
    Venditti M; Iwasiow B; Orr FW; Shiu RP
    Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
    DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
    Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.
    Brünner N; Frandsen TL; Holst-Hansen C; Bei M; Thompson EW; Wakeling AE; Lippman ME; Clarke R
    Cancer Res; 1993 Jul; 53(14):3229-32. PubMed ID: 8324732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new MCF-7 breast cancer cell line resistant to the arzoxifene metabolite desmethylarzoxifene.
    Freddie CT; Christensen GL; Lykkesfeldt AE
    Mol Cell Endocrinol; 2004 May; 220(1-2):97-107. PubMed ID: 15196704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
    Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
    Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family.
    Larsen SS; Egeblad M; Jäättelä M; Lykkesfeldt AE
    Breast Cancer Res Treat; 1999 Nov; 58(1):41-56. PubMed ID: 10634517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
    Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
    J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines.
    Cho HS; NG PA; Katzenellenbogen BS
    Mol Endocrinol; 1991 Sep; 5(9):1323-30. PubMed ID: 1722871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.
    Banerjee S; Saxena N; Sengupta K; Tawfik O; Mayo MS; Banerjee SK
    Neoplasia; 2003; 5(1):63-73. PubMed ID: 12659671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of cytochrome p450 1A1 and 1B1 genes in anti-estrogen-resistant human breast cancer cell lines.
    Brockdorff BL; Skouv J; Reiter BE; Lykkesfeldt AE
    Int J Cancer; 2000 Dec; 88(6):902-6. PubMed ID: 11093812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.
    Santen R; Jeng MH; Wang JP; Song R; Masamura S; McPherson R; Santner S; Yue W; Shim WS
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):115-25. PubMed ID: 11850215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.
    Couissi D; Dubois V; Remacle C; Schonne E; Trouet A
    Clin Exp Metastasis; 1997 Jul; 15(4):349-60. PubMed ID: 9219723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.